Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Calumet Specialty Products Partners Completes Acquisition Of Royal Purple

RELATED NEWS
Trade CLMT now with 
7/3/2012 4:40 PM ET

Calumet Specialty Products Partners L.P. (CLMT: Quote) announced that it completed the previously announced acquisition of Royal Purple Inc. on July 3, 2012 for aggregate consideration of about $333 million, subject to customary purchase price adjustments.

The Royal Purple Acquisition was financed with the net proceeds of approximately $262 million from the June 2012 issuance of $275 million in aggregate principal amount of Calumet's 9 5/8% senior unsecured notes due 2020 and with cash on hand of approximately $71 million.

Click here to receive FREE breaking news email alerts for Calumet Specialty Products Partners L.P. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Publishing and design software maker Adobe Systems Inc. said Tuesday after the markets closed that its second quarter profit fell 66% from last year, hurt by lower revenue as well as higher costs and expenses. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations and its quarterly revenue was in line with analysts' forecast. Stocks showed a strong upward move over the course of the trading day on Tuesday, adding to the gains posted in the previous session. The rally came even as traders expressed some uncertainty ahead of tomorrow's Federal Reserve announcement. The major averages gave back some ground going into the close but remained firmly in positive territory. In a potential roadblock to comprehensive immigration reform legislation, House Speaker John Boehner, R-Ohio, indicated Tuesday that he would not bring a bill to the floor unless it is supported by a majority of House Republicans.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.